Transseptal Access Systems Market
Global Market Study on Transseptal Access Systems: Hospitals to Remain Key End Users with 50% Market Share
Transseptal Access Systems Market Segmented By Transseptal Access Sheaths, Transseptal Access Needles Production by AF Ablation, MV Repair, LAA Occlusion in Hospitals, Ambulatory Surgical Centers, Specialty Clinics
Global demand for transseptal access systems is set to experience significant growth at 9.4% CAGR through 2031, with the market value around US$ 845 Mn at present. As per Persistence Market Research’s projections, transseptal access sheath hold a substantial share of around 86% in the overall market.
Find Out More about the Report Coverage
- Terumo Corporation
- Medtronic PLC
- St. Jude Medical (Abbott Laboratories)
- Boston Scientific
- Biosense Webster, Inc. (Johnson & Johnson)
- Merit Medical Systems, Inc.
- Baylis Medical Company Inc.
- Pressure Products Medical Device Manufacturing LLC
- Cook Medical LLC
- Transseptal Solutions, Inc.
Key Insights Covered in Transseptal Access Systems Industry Survey:
- Market Estimates and Forecasts (2016-2031)
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Market Share Analysis By Key Players
- Key Product Innovations and Regulatory Climate
- COVID-19 Impact on Demand for Transseptal Access Systems and How to Navigate
- Recommendation on Key Winning Strategies
Customize this Report
Explore Intelligence Tailored to Your Business Goals.
Sales Analysis of Transseptal Access Systems from 2016 to 2020 Vs Market Outlook for 2021 to 2031
The global transseptal access systems market expanded at 6.7% CAGR from 2016 to 2020.
Catheterization of the left atrium to do ablation of arrhythmia via a transseptal puncture using transseptal access systems is gaining interest. The geriatric population with a high risk of conditions such as hypertension is increasing the cardiac patient population. Additionally, intake of alcohol, tobacco, and changing lifestyles are common factors that can cause conditions such as atrial fibrillation.
Rising prevalence of atrial fibrillation in developing and developed countries creates a necessity for effective atrial fibrillation techniques such as atrial fibrillation ablation therapy, mitral valve repair, and LLA occlusion therapy.
Furthermore, improvements in healthcare infrastructure in emerging markets will provide several opportunities for market expansion during the forecast period.
The market is expected to expand at a considerable growth rate over the next ten years at a CAGR of 9.4%.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
What are the Recent Trends Shaping the Transseptal Access Systems Industry?
Growing awareness among individuals and increasing technological advancements in transseptal access systems are expected to drive demand. Introduction of a combination of transesophageal and fluoroscopic echocardiographic images is accountable for progress in transseptal puncture techniques.
Similarly, mechanical advancements and launch of innovative products with additional benefits are estimated fast-track demand for transseptal access systems. For instance, availability of AVANCE Bi-directional steerable introducer sheaths designed to have even bending features in every direction encourages ease of access into the left atrium during transseptal access.
Key manufacturers of transseptal access systems are adopting collaborative strategies to enhance product penetration across emerging regions.
Explore Persistence Market Research’s expertise in promulgation of the business !
Which Factors are Restraining Demand for Transseptal Access Systems?
Growing incidence of atrial fibrillation led to an increase in demand for transseptal access systems globally. However, there is unavailability of healthcare service practitioners to operate these systems.
Other factors, including supply chain issues, inefficient management of healthcare services, non-availability of technologically advanced equipment, etc., result in reduced adoption of transseptal access systems, thereby hampering market growth.
Why are Sales of Transseptal Access Systems Soaring across the U.S.?
The U.S. dominates the North American region with a total market share of 86%, and is projected to experience high growth throughout the forecast period.
Advancements in healthcare facilities, efficient healthcare policies in the U.S., and easy access to various diagnostic and treatment services have resulted in increased human life expectancy, which, in turn, is leading to an increase in the geriatric population.
According to the United Nations Population Fund 2014, around 11% of the global population was constituted by people aged 60 and above; this is expected to increase to 22% by 2050
Atrial fibrillation is the most common arrhythmia diagnosed in clinical practice. Estimates of the prevalence of atrial fibrillation in the United States range from 2.7 million to 6.1 million. This number is estimated to rise to 12.1 million by 2030. As per the Centers for Disease Control and Prevention (CDC) Trusted Source, around 2& of people below 65 years have atrial fibrillation, whereas, around 9% of people ages 65 and older have it.
Why is Germany Considered a Lucrative Market for Transseptal Access Systems in Europe?
Germany dominates the European market for transseptal access systems with a share of 25%. Continuous increase in the prevalence and incidence rate of atrial fibrillation in European countries creates the need for increase in atrial fibrillation procedures such as LLA occlusion therapy, atrial fibrillation ablation therapy, and mitral valve repair.
According to a research conducted, it has been estimated that atrial fibrillation affects approximately 0.5% to 1.0% of the general European population. In Germany, approximately 2% of the population is affected by atrial fibrillation. This results in increasing surgical procedures that include transseptal puncture to access the left atrium of the heart and demands the need for transseptal access systems.
What Makes India an Emerging Market for Transseptal Access Systems in South Asia?
India holds a 7% share in the South Asia market and the market is anticipated to expand at a CAGR of over 10%.
Prevalence of rheumatic valvular heart disease in South Asia countries is on a continuous rise. According to data published in the Indian Journal of Medical Research (IJMR), overall prevalence of RHD is estimated to be 1.5-2.0/1000 in all age groups. In India (total population of 1.3 billion) there are about 2.0-2.5 million patients of RHD.
Furthermore, prevalence of atrial fibrillation in Asian countries is around 1% of the total adult population, lower than in Western countries by 2%. The prime reason is often associated with a large geriatric population base.
By the end of 2050, Asia Pacific will have more than 72 million patients suffering from atrial fibrillation, more than the combined patient population of Europe and the U.S.; Approximately 2.8 million will have atrial fibrillation related stroke cases.
What is Hampering Demand of Transseptal Access Systems in South Africa?
Despite various regional as well as global support and improvements in healthcare facilities, vast majority of people still have poor access to treatment options. Factors such as lack of skilled personnel, inadequate service providers, poor awareness of disease symptoms, poverty, supply chain issues, inefficient management of healthcare services, non-availability of technologically advanced equipment, etc., are prevalent.
These factors reduce product consumption despite its high requirement, thus restraining market growth of transseptal access systems. Lack of skilled personnel is also a prime obstacle to the growth of the market in South Africa.
Which Transseptal Access Product are Driving Market Growth?
By product, transseptal access sheaths will lead the market with a share of 86% over the forecast period.
Wide adoption of transseptal access sheaths in a majority of PTMC and AFib procedures with improved left atrium access, tissue contact, manoeuvrability, and associated with superior clinical outcomes are driving segment growth.
Why is Atrial Fibrillation Ablation Increasing Demand for Transseptal Access Systems?
The atrial fibrillation ablation segment dominates the market with 65% revenue. Demand for catheter-based atrial fibrillation ablation has tremendously increased over the past decade. With increasing reimbursement and other government policies for heart patients, further increase in treatment demand is expected.
Various public health initiatives and government programs to support and create awareness have also increased, and this has moved people to undergo certain treatments. For instance, September is National Atrial Fibrillation Awareness month, which is known to be the most valuable period for the Heart Rhythm Society to create awareness for life-threatening arrhythmia.
What is the Impact of COVID-19 on the Transseptal Access Systems Space?
The outbreak of novel coronavirus has indirectly demand for affected transseptal access systems by delaying atrial fibrillation ablation procedures and reducing the volume of procedures during the pandemic.
As per new guidelines submitted by the American College of Cardiology (ACC) and American Heart Association (AHA), triaging of the procedure has been done by separating patients into non-urgent, semi-urgent, and urgent.
What is the Impact of Market Consolidation on the Transseptal Access Systems Business Sector?
Increasing industrial expansion activities such as acquisition of ablation devices companies by major market players to introduce innovative products and technologies will bring significant opportunities to gain trust in customers’ minds. Increasing strategic acquisitions of start-ups is expected to broaden technology and product offerings by key players in a volatile market.
- On December, 2020, Acutus Medical received CE Mark and European approval for AcQCross Transseptal System, a Fully Integrated Family of Transseptal Crossing Products and have launched system to Improve Safety and Efficiency in Any Procedure Requiring Left Heart Access.
- On May 2019, Acutus Medical acquired Rhythm Xience inc. this Partnership add access, therapy, diagnostics and rhythm monitoring solutions to Acutus’ portfolio.
In this market, the presence of manufacturers is limited. Manufacturers are focused on expansion to increase their penetration in emerging economies.
Recent developments related to companies manufacturing transseptal access systems have been tracked by the team at Persistence Market Research, which are available in the full report.
Transseptal Access Systems Industry Report Scope
Historical Data Available for
US$ Mn for Value
Key Regions Covered
Key Countries Covered
Key Market Segments Covered
Key Companies Profiled
Available upon Request
Key Segments Covered in Transseptal Access Systems Industry Research
- Transseptal Access Needles
- Standard Curve (C0) Needles
- Large Curve (C1) Needles
- Transseptal Access Sheaths
- Steerable Sheaths
- Fixed Sheaths
- Atrial Fibrillation Ablation
- Mitral Valve Repair
- Left Atrial Appendage Occlusion
- Transseptal Access Systems for Hospitals
- Transseptal Access Systems for Ambulatory Surgical Centers
- Transseptal Access Systems for Speciality Clinics
Enquiry before Buying
- Is the market research conducted by Persistence Market Research?
Yes, the report filled with transseptal access systems market insights has been compiled by expert analysts of Persistence Market Research, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
- What research methodology is followed by Persistence Market Research?
Persistence Market Research follows a methodology that encompasses the demand-side assessment and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
- Who are the respondents for primary research?
Persistence Market Research speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
- What are the sources of secondary research?
Persistence Market Research conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
- Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through email.
- How can I buy this report?
Persistence Market Research provides a secure online payment system to buy reports seamlessly. You can buy the report securely and safely.